Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Winder

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Diabetes Technology & Therapeutics|July 27, 2001
AMP-activated protein kinase: possible target for treatment of type 2 diabetesW W Winder
The American Journal of Physiology|March 1, 1979
Time course of the T3- and T4-induced increase in rat soleus muscle mitochondriaW W Winder
Advances in Experimental Medicine and Biology|October 22, 1998
Intramuscular mechanisms regulating fatty acid oxidation during exerciseW W Winder
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 18, 2001
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscleW W Winder
Medicine and Science in Sports and Exercise|April 1, 1986
Effect of intravenous caffeine on liver glycogenolysis during prolonged exerciseW W Winder
Medicine and Science in Sports and Exercise|December 1, 1988
Role of cyclic AMP in regulation of hepatic glucose production during exerciseW W Winder
Exercise and Sport Sciences Reviews|August 11, 1998
Malonyl-CoA--regulator of fatty acid oxidation in muscle during exerciseW W Winder
Exercise and Sport Sciences Reviews|January 1, 1985
Regulation of hepatic glucose production during exerciseW W Winder
Medicine and Science in Sports and Exercise|February 1, 1985
Control of hepatic glucose production during exerciseW W Winder
Diabetologia|August 13, 2008
Can patients with type 2 diabetes be treated with 5'-AMP-activated protein kinase activators?W W Winder
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Diabetes Technology & Therapeutics|July 27, 2001
AMP-activated protein kinase: possible target for treatment of type 2 diabetesW W Winder
The American Journal of Physiology|March 1, 1979
Time course of the T3- and T4-induced increase in rat soleus muscle mitochondriaW W Winder
Advances in Experimental Medicine and Biology|October 22, 1998
Intramuscular mechanisms regulating fatty acid oxidation during exerciseW W Winder
Journal of Applied Physiology (Bethesda, Md. : 1985)|August 18, 2001
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscleW W Winder
Medicine and Science in Sports and Exercise|April 1, 1986
Effect of intravenous caffeine on liver glycogenolysis during prolonged exerciseW W Winder
Medicine and Science in Sports and Exercise|December 1, 1988
Role of cyclic AMP in regulation of hepatic glucose production during exerciseW W Winder
Exercise and Sport Sciences Reviews|August 11, 1998
Malonyl-CoA--regulator of fatty acid oxidation in muscle during exerciseW W Winder
Exercise and Sport Sciences Reviews|January 1, 1985
Regulation of hepatic glucose production during exerciseW W Winder
Medicine and Science in Sports and Exercise|February 1, 1985
Control of hepatic glucose production during exerciseW W Winder
Diabetologia|August 13, 2008
Can patients with type 2 diabetes be treated with 5'-AMP-activated protein kinase activators?W W Winder
Pageof 13